Table 2 Patients’ CYP1A2 and CYP3A status.

From: Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia

CYP genotype

N

%

CYP1A2

*1/*1

14

14.6

*1/*1F

36

37.5

*1F/*1F

45

46.9

*1C/*1F

1

1.0

CYP3A4

*1/*1

78

81.3

*1/*1B

6

6.2

*1/*22

12

12.5

CYP3A5

*1/*3

10

10.4

*3/*3

86

89.6

CYP expression

CYP1A2

Low expresser

62

64.6

Normal expresser

33

34.4

High expresser

1

1.0

CYP3A4

Low expresser

23

24.0

Normal expresser

72

75.0

High expresser

1

1.0